Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05220332 · ClinicalTrials.gov registry record · NA

Church-based Intervention to Improve Blood Pressure in African Americans

A NA study of Hypertension, sponsored by Rush University Medical Center.

Recruiting
Registry status
NA
Development phase
312
Enrollment target
1
Study location

NCT05220332 is a NA study of Hypertension that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 312 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05220332, a NA study of Hypertension, is actively recruiting participants, sponsored by Rush University Medical Center.

RECRUITING
Registry status
NA
Development phase
312 participants
Enrollment target
1
Study location

Study Summary

This is a 12-month behavioral cluster-randomized trial testing a church-based intervention to reduce blood pressure in African Americans with uncontrolled blood pressure.

Conditions Studied

Interventions

  • BEHAVIORAL Heart to Heart
  • BEHAVIORAL Money Smart

Study Locations (1)

Illinois

  • Rush University Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 312 participants
Start Date 2022-03-15
Est. Completion 2026-07
Phase NA

Sponsor

Rush University Medical Center

320 total trials

What the Registry Record Tells You About NCT05220332

The ClinicalTrials.gov registry entry for NCT05220332 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 312 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (91% lower). The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Heart to Heart is the first listed.

NCT05220332 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05220332 about?

NCT05220332 is a clinical study titled "Church-based Intervention to Improve Blood Pressure in African Americans". This is a 12-month behavioral cluster-randomized trial testing a church-based intervention to reduce blood pressure in African Americans with uncontrolled blood pressure.

What is the current status of trial NCT05220332?

This trial is currently recruiting. It is a NA study. The enrollment target is 312 participants. The study started on 2022-03-15. Estimated completion is 2026-07.

What conditions does trial NCT05220332 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT05220332?

The interventions under investigation include: Heart to Heart (BEHAVIORAL), Money Smart (BEHAVIORAL).

Who is sponsoring clinical trial NCT05220332?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05220332 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.